PRELIMINARY INFORMATION STATEMENT SUBJECT TO COMPLETION
PPD, Inc.
929 North Front Street
Wilmington, North Carolina 28401
The following information
is being provided to amend PPD Inc.s (the Company) preliminary information statement filed with the Securities and Exchange Commission on May 14, 2021 (the information statement). Text that is bold and struck
through in the disclosures below shows text being removed from those disclosures and text that is bold and underlined below shows text being added to those disclosures. Terms used but not otherwise defined herein have the meanings given to them in
the information statement, and all references to captions and page numbers refer to captions and page numbers in the information statement, respectively, unless otherwise provided.
Except as otherwise set forth below, the information set forth in the information statement remains unchanged and is incorporated by reference as relevant to the items in
this Amendment No. 1 to the information statement.
THE INFORMATION STATEMENT CONTAINS IMPORTANT ADDITIONAL INFORMATION AND THIS AMENDMENT SHOULD BE READ IN
CONJUNCTION WITH THE INFORMATION STATEMENT. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
1. The first paragraph in the section
entitled SummaryRegulatory Approvals (page 43) on page 7 of the information statement is amended and restated in its entirety as follows:
Under the HSR Act and related rules, certain transactions, including the Merger, may not be completed until notifications have been given and information
furnished to the Antitrust Division of the United States Department of Justice (Antitrust Division) and the Federal Trade Commission (FTC) and all statutory waiting period requirements have been satisfied or early termination
has been granted by the applicable agencies. On April May 13, 2021, both the Company and Thermo Fisher filed their respective notification and report forms under the HSR Act.
2. The second paragraph in the section entitled The MergerRegulatory Approvals on page 43 of the information statement is amended and restated in
its entirety as follows:
Under the HSR Act and related rules, certain transactions, including the Merger, may not be completed until notifications
have been given and information furnished to the Antitrust Division and the FTC and all statutory waiting period requirements have been satisfied or early termination has been granted by the applicable agencies. On April
May 13, 2021, both the Company and Thermo Fisher filed their respective notification and report forms under the HSR Act and requested early termination of the initial 30-day waiting period under the HSR Act.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly
and current reports, proxy statements, and other documents with the SEC. These reports contain additional information about the Company. Stockholders may read and copy any reports, statements or other information filed by the Company at the
SECs Public Reference Room, 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of this information by mail from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates.
Please call the SEC at (800) SEC-0330 for further information on the operation of the Public Reference Room. The Companys SEC filings are made electronically available to the public at the SECs website located at
www.sec.gov. Stockholders can also obtain free copies of our SEC filings through the Investor Relations section of the Companys website at https://investors.ppd.com/investor-relations. Our website address is being provided as an
inactive textual reference only. The information provided on, or accessible through, our website, other than the copies of the documents listed or referenced in the information statement that have been or will be filed with the SEC, is not part of
the information statement, as amended, and therefore is not incorporated herein by reference.
The Company undertakes to provide without charge to each person to whom
a copy of the information statement, as amended, has been delivered, upon written or oral request, by first class mail or other equally prompt means within one business day of receipt of such request, a copy of any or all of the documents
incorporated by reference in the information statement, as amended, other than the exhibits to these documents, unless the exhibits are specifically incorporated by reference into the information that the information statement, as amended,
incorporates. You may request a copy of these filings by telephone at (910) 251-0081 or by writing to us at:
Investor Relations
929 North Front Street
Wilmington, NC 28401
e-mail: Investors@ppd.com
Thermo Fisher and Merger Sub have
supplied, and the Company has not independently verified, the information in the information statement, as amended, relating to Thermo Fisher and Merger Sub.
Stockholders should not rely on information that purports to be made by or on behalf of the Company other than that contained in or incorporated by reference in the
information statement, as amended. The Company has not authorized anyone to provide information on behalf of the Company that is different from that contained in the information statement, as amended. This Amendment No. 1 to the information
statement is dated , 2021. No assumption should be made that the information contained in the information statement, as
amended, is accurate as of any date other than that date, and the mailing of the information statement, as amended, will not create any implication to the contrary.